Open AccessAssessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen
Author(s) -
Monalisa Das,
Patralekha Ray Chaudhuri,
Badal Chandra Mondal,
Sukumar Mitra,
Debkumar Bandyopadhyay,
Sushobhan Pramanik
Publication year - 2015
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/0253-7613.165183
Subject(s) - medicine , magnesium , eclampsia , hypermagnesemia , anesthesia , regimen , apgar score , loading dose , hypotonia , pregnancy , gestational age , hypomagnesemia , genetics , materials science , metallurgy , biology
Magnesium historically has been used for treatment and/or prevention of eclampsia. Considering the low body mass index of Indian women, a low-dose magnesium sulfate regime has been introduced by some authors. Increased blood levels of magnesium in neonates is associated with increased still birth, early neonatal death, birth asphyxia, bradycardia, hypotonia, gastrointestinal hypomotility. The objective of this study was to assess safety of low-dose magnesium sulfate regimen in neonates of eclamptic mothers treated with this regimen.